Compare IMMX & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMX | CCSI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 784.8M | 648.0M |
| IPO Year | 2021 | 2022 |
| Metric | IMMX | CCSI |
|---|---|---|
| Price | $9.44 | $36.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $24.30 | ★ $42.25 |
| AVG Volume (30 Days) | ★ 1.4M | 102.3K |
| Earning Date | 11-06-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.72 |
| Revenue | N/A | ★ $349,696,000.00 |
| Revenue This Year | N/A | $3.01 |
| Revenue Next Year | N/A | $3.66 |
| P/E Ratio | ★ N/A | $13.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $20.20 |
| 52 Week High | $15.10 | $41.40 |
| Indicator | IMMX | CCSI |
|---|---|---|
| Relative Strength Index (RSI) | 33.13 | 53.44 |
| Support Level | $7.96 | $32.99 |
| Resistance Level | $10.40 | $39.20 |
| Average True Range (ATR) | 0.76 | 1.15 |
| MACD | -0.23 | 0.19 |
| Stochastic Oscillator | 11.55 | 90.24 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.